Unrelieved pain occurs in approximately 55% of oncology patients during active treatment and over 35% of these patients report moderate to severe pain.111 Outpatients receiving chemotherapy can experience pain as a result of the cancer itself, associated treatments (e.g., chemotherapy-induced peripheral neuropathy, aromatase inhibitors-induced arthralgia, granulocyte-colony stimulating factors-induced bone pain), and/or other comorbid conditions (e.g., musculoskeletal disorders).22, 77, 88, 108 Despite the tremendous symptom burden associated with unrelieved pain, as well as the significant decrements in quality of life (QOL) and overall survival,114 numerous studies found that oncology outpatients do not receive adequate pain management.
from The Journal of Pain https://ift.tt/3BnFb8D
via IFTTT
No comments:
Post a Comment